Abstract
Waking neurobehavioral performance is temporally regulated by a sleep/wake homeostatic process and a circadian process in interaction with a time-on-task effect. Neurobehavioral impairment resulting from these factors is taskspecific, and characterized by performance variability. Several aspects of these phenomena are not well understood, and cannot be explained solely by a top-down (subcortically driven) view of sleep/wake and performance regulation. We present a bottom-up theory, where we postulate that task performance is degraded by local, use-dependent sleep in neuronal groups subserving cognitive processes associated with the task at hand. The theory offers explanations for the temporal dependence of neurobehavioral performance on time awake, time on task, and their interaction; for the effectiveness of task switching and rest breaks to overcome the time-on-task effect (but not the effects of sleep deprivation); for the taskspecific nature of neurobehavioral impairment; and for the stochastic property of performance variability.
Keywords: Use-dependence, cognition, time on task, state instability, sleep homeostasis, near-infrared optical imaging, theory development, neurobehavioral performance, neurobehavioral impairment, stochastic property, behavioral domains, subjective sleepiness, homeostatic process, exogenous stimuli, evolutionary advantage
Current Topics in Medicinal Chemistry
Title: A Local, Bottom-Up Perspective on Sleep Deprivation and Neurobehavioral Performance
Volume: 11 Issue: 19
Author(s): Hans P.A. Van Dongen, Gregory Belenky and James M. Krueger
Affiliation:
Keywords: Use-dependence, cognition, time on task, state instability, sleep homeostasis, near-infrared optical imaging, theory development, neurobehavioral performance, neurobehavioral impairment, stochastic property, behavioral domains, subjective sleepiness, homeostatic process, exogenous stimuli, evolutionary advantage
Abstract: Waking neurobehavioral performance is temporally regulated by a sleep/wake homeostatic process and a circadian process in interaction with a time-on-task effect. Neurobehavioral impairment resulting from these factors is taskspecific, and characterized by performance variability. Several aspects of these phenomena are not well understood, and cannot be explained solely by a top-down (subcortically driven) view of sleep/wake and performance regulation. We present a bottom-up theory, where we postulate that task performance is degraded by local, use-dependent sleep in neuronal groups subserving cognitive processes associated with the task at hand. The theory offers explanations for the temporal dependence of neurobehavioral performance on time awake, time on task, and their interaction; for the effectiveness of task switching and rest breaks to overcome the time-on-task effect (but not the effects of sleep deprivation); for the taskspecific nature of neurobehavioral impairment; and for the stochastic property of performance variability.
Export Options
About this article
Cite this article as:
P.A. Van Dongen Hans, Belenky Gregory and M. Krueger James, A Local, Bottom-Up Perspective on Sleep Deprivation and Neurobehavioral Performance, Current Topics in Medicinal Chemistry 2011; 11 (19) . https://dx.doi.org/10.2174/156802611797470286
DOI https://dx.doi.org/10.2174/156802611797470286 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances and Application of a Novel Oral Anticoagulant in Specific Populations: Dabigatran Etexilate
Current Drug Metabolism CRF Receptor Antagonists: Utility in Research and Clinical Practice
Current Medicinal Chemistry Hypoplastic Left Circumflex Coronary Artery: Imaging Findings with Coronary Computed Tomography Angiography - A Case Report
Current Medical Imaging The Intermediate Enzymes of Isoprenoid Metabolism as Anticancer Targets
Anti-Cancer Agents in Medicinal Chemistry The Role of Renin Angiotensin System Blockade in the Treatment of Atrial Fibrillation
Current Drug Targets - Cardiovascular & Hematological Disorders Alcohol Induced Hepato Cardiotoxicity and Oxidative Damage in Rats: The Protective Effect of n-butanol Extract of Green Tea (Camellia sinensis (L.) Kuntze)
Cardiovascular & Hematological Disorders-Drug Targets Pre-eclampsia Versus Cardiovascular Disease Versus CRP
Current Hypertension Reviews Expressions of eNOS3 and Ve-Cadherin in Microvascular Endothelium at 7-Day of Reperfused Acute Myocardial Infarction
Cardiovascular & Hematological Disorders-Drug Targets Association of High-sensitivity C-reactive Protein with Patient Prognosis Following Mechanical Thrombectomy for Acute Ischemic Stroke
Current Neurovascular Research Therapeutic Potential and Strategies Against Leukocyte-Platelet Interaction in Atherosclerosis
Current Vascular Pharmacology Vascular Oxidative Stress: A Key Factor in the Development of Hypertension Associated with Ethanol Consumption
Current Hypertension Reviews Cardiac Role of the Transcription Factor NF-κB
Cardiovascular & Hematological Disorders-Drug Targets Diabetic Cognitive Dysfunction: From Bench to Clinic
Current Medicinal Chemistry The Therapeutic Potential of Purinergic Receptors in Alzheimer’s Disease and Promising Therapeutic Modulators
Mini-Reviews in Medicinal Chemistry Risk of Bleeding Related to Antithrombotic Treatment in Cardiovascular Disease
Current Pharmaceutical Design Obesity, Metabolic Syndrome, Diabetes and Arterial Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Challenges in Moving from Ageing to Successful Longevity
Current Vascular Pharmacology An Update on the Association of Protein Kinases with Cardiovascular Diseases
Current Pharmaceutical Design Insulin Secretion and Interleukin-1β Dependent Mechanisms in Human Diabetes Remission After Metabolic Surgery
Current Medicinal Chemistry ACKNOWLEDGEMENTS TO REVIEWERS
Cardiovascular & Hematological Agents in Medicinal Chemistry